Compass Wealth Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.23M Sell
11,051
-849
-7% -$427K 1.29% 28
2025
Q4
$5.56M Sell
11,900
-132
-1% -$61.3K 1.39% 27
2025
Q3
$5.13M Sell
12,032
-715
-6% -$277K 1.15% 30
2025
Q2
$4.88M Sell
12,747
-260
-2% -$93.7K 1.16% 31
2025
Q1
$4.49M Sell
13,007
-2,139
-14% -$688K 1.15% 31
2024
Q4
$4.55M Sell
15,146
-475
-3% -$166K 1.09% 32
2024
Q3
$6.35M Sell
15,621
-671
-4% -$246K 1.49% 14
2024
Q2
$5.23M Sell
16,292
-115
-0.7% -$37.4K 1.29% 23
2024
Q1
$5.47M Sell
16,407
-330
-2% -$101K 1.37% 20
2023
Q4
$4.53M Sell
16,737
-476
-3% -$118K 1.27% 23
2023
Q3
$4.23M Sell
17,213
-265
-2% -$72.5K 1.33% 21
2023
Q2
$5.3M Sell
17,478
-300
-2% -$83.4K 1.6% 13
2023
Q1
$4.69M Sell
17,778
-1,190
-6% -$302K 1.49% 13
2022
Q4
$4.55M Buy
+18,968
New +$4.25M 1.49% 15

Other funds holding HCA

Compass Wealth Management's HCA Position: Q1 2026 in Review

Compass Wealth Management reduced its HCA Healthcare (HCA) stake by 7.1% in Q1 2026, selling an estimated $427K and leaving 11,051 shares worth $5.23M. The position accounts for 1.29% of the portfolio, ranked #28.

Compass Wealth Management first reported a position in HCA in Q4 2022 and has held it in 14 quarters since. The position peaked at $6.35M in Q3 2024. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Compass Wealth Management held 11,051 shares of HCA Healthcare worth $5.23M as of Q1 2026.
  • Compass Wealth Management sold 849 HCA Healthcare shares in Q1 2026, an estimated $427K.
  • HCA Healthcare made up 1.29% of Compass Wealth Management's portfolio in Q1 2026, its #28 holding.
  • Compass Wealth Management first reported a position in HCA Healthcare in Q4 2022 and has held it in 14 quarters since.
  • Compass Wealth Management's HCA Healthcare position peaked at $6.35M in Q3 2024.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Compass Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.